Upgrade to SI Premium - Free Trial

Aclarion (ACON)

2.45 -0.10 (3.92%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/28/26)

Latest Headlines

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice July 21, 2026 7:00 AM - Globe NewsWire Form S-8 Aclarion, Inc. July 9, 2026 8:00 AM - SEC Filing Aclarion adds Texas Spine Care Center to CLARITY trial network July 7, 2026 7:02 AM - StreetInsider Aclarion Announces Texas Spine Care Center as New CLARITY Site July 7, 2026 7:00 AM - Globe NewsWire Form 4 Aclarion, Inc. For: Jun 11 Filed by: Bond Ryan June 12, 2026 4:31 PM - SEC Filing Form 4 Aclarion, Inc. For: Jun 11 Filed by: Breidbart Scott June 12, 2026 4:31 PM - SEC Filing Form 4 Aclarion, Inc. For: Jun 11 Filed by: Sequira Amanda Mae June 12, 2026 4:31 PM - SEC Filing Form 4 Aclarion, Inc. For: Jun 11 Filed by: Wesemann William June 12, 2026 4:31 PM - SEC Filing Form 4 Aclarion, Inc. For: Jun 11 Filed by: Gould Gregory A June 12, 2026 4:31 PM - SEC Filing Form 4 Aclarion, Inc. For: Jun 11 Filed by: Ness Brent June 12, 2026 4:31 PM - SEC Filing Form 4 Aclarion, Inc. For: Jun 11 Filed by: Neal David K June 12, 2026 4:31 PM - SEC Filing Form 4 Aclarion, Inc. For: Jun 11 Filed by: Thramann Jeffrey John June 12, 2026 4:31 PM - SEC Filing Form 4 Aclarion, Inc. For: Jun 11 Filed by: Deitsch Stephen June 12, 2026 4:31 PM - SEC Filing Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub June 10, 2026 7:00 AM - Globe NewsWire Aclarion partners with PRIA Healthcare for Nociscan reimbursement strategy June 9, 2026 7:01 AM - StreetInsider Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform June 9, 2026 7:00 AM - Globe NewsWire Aclarion rejects Echo Lake Capital's $4 per share acquisition offer June 8, 2026 7:05 AM - StreetInsider Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal June 8, 2026 7:05 AM - Globe NewsWire Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting June 8, 2026 7:00 AM - Globe NewsWire Form 8-K Aclarion, Inc. For: Jun 04 June 4, 2026 4:50 PM - SEC Filing Aclarion partners with Institute of Neuro Innovation for Nociscan expansion June 3, 2026 6:00 AM - StreetInsider Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation June 3, 2026 6:00 AM - Globe NewsWire Aclarion technology used in back pain study exploring immune factors June 1, 2026 6:00 AM - StreetInsider Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study June 1, 2026 6:00 AM - Globe NewsWire Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal May 28, 2026 2:49 PM - Globe NewsWire Echo Lake Capital offers to buy Aclarion for $4 per share plus CVR May 28, 2026 8:00 AM - StreetInsider Echo Lake Capital Offers To Acquire Aclarion Inc. May 28, 2026 8:00 AM - StreetInsider Form 10-Q Aclarion, Inc. For: Mar 31 May 13, 2026 4:31 PM - SEC Filing Form 4 Aclarion, Inc. For: May 12 Filed by: Breidbart Scott May 12, 2026 6:53 PM - SEC Filing Form 4 Aclarion, Inc. For: May 11 Filed by: Neal David K May 12, 2026 8:30 AM - SEC Filing Form 4 Aclarion, Inc. For: May 11 Filed by: Ness Brent May 11, 2026 4:31 PM - SEC Filing Form 4 Aclarion, Inc. For: May 06 Filed by: Wesemann William May 8, 2026 5:01 PM - SEC Filing Aclarion adds Beverly Hills spine practice to CLARITY trial May 7, 2026 6:01 AM - StreetInsider Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment May 7, 2026 6:00 AM - Globe NewsWire Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. May 6, 2026 6:00 AM - Globe NewsWire Aclarion signs second commercial deal with Weill Cornell Medicine May 5, 2026 6:01 AM - StreetInsider Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine May 5, 2026 6:00 AM - Globe NewsWire Aclarion reports 196% growth in scan volumes for Q1 April 30, 2026 6:01 AM - StreetInsider Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption April 30, 2026 6:00 AM - Globe NewsWire Aclarion names Daniel Keefe commercial director for western US April 28, 2026 6:00 AM - StreetInsider Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan April 28, 2026 6:00 AM - Globe NewsWire Form DEF 14A Aclarion, Inc. For: Jun 04 April 27, 2026 4:05 PM - SEC Filing Full Article List